Related references
Note: Only part of the references are listed.Regulation of nausea and vomiting by cannabinoids
Linda A. Parker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
R. Pineiro et al.
ONCOGENE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Bone cancer pain
Juan Miguel Jimenez-Andrade et al.
NEURONS AND NETWORKS IN THE SPINAL CORD (2010)
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
V. Curto-Reyes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Lesley A. Ford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
Iain Brown et al.
CARCINOGENESIS (2010)
Understanding and Optimizing Bone Health in Breast Cancer
Theresa A. Guise et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza et al.
ENDOCRINE-RELATED CANCER (2010)
Prostate cancer incidence and mortality trends in 37 European countries: An overview
F. Bray et al.
EUROPEAN JOURNAL OF CANCER (2010)
Effects of cannabis on lung function: a population-based cohort study
R. J. Hancox et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone Pain
Juan M. Jimenez-Andrade et al.
JOURNAL OF NEUROSCIENCE (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Maria M. Caffarel et al.
MOLECULAR CANCER (2010)
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
Alysia N. Lozano-Ondoua et al.
LIFE SCIENCES (2010)
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4
Lina Thors et al.
PLOS ONE (2010)
Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain
Louis Dore-Savard et al.
PLOS ONE (2010)
Circulating tumour cells in cancer patients: challenges and perspectives
Klaus Pantel et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
Mia Djulbegovic et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
Judith V. M. G. Bovee et al.
NATURE REVIEWS CANCER (2010)
Reduction of Bone Cancer Pain by Activation of Spinal Cannabinoid Receptor 1 and Its Expression in the Superficial Dorsal Horn of the Spinal Cord in a Murine Model of Bone Cancer Pain
Shingo Furuse et al.
ANESTHESIOLOGY (2009)
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
N. Olea-Herrero et al.
BRITISH JOURNAL OF CANCER (2009)
Marijuana and chronic obstructive lung disease: a population-based study
Wan C. Tan et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Sui Chu Chung et al.
EUROPEAN JOURNAL OF CANCER (2009)
Antiemetic control: toward a new standard of care for emetogenic chemotherapy
Rudolph M. Navari
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma
Gabriella Czifra et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
The cannabinoid R(+) methanandamide induces IL-6 secretion by prostate cancer PC3 cells
Nuria Olea-Herrero et al.
JOURNAL OF IMMUNOTOXICOLOGY (2009)
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Zahida Qamri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Biology of endocannabinoid synthesis system
Jun Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Modulation of Δ9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase
Shuso Takeda et al.
TOXICOLOGY (2009)
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Tamas Biro et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation
Sumner Burstein et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
Carl Potenzieri et al.
BRAIN RESEARCH (2008)
Cannabinoids for cancer treatment: Progress and promise
Sami Sarfaraz et al.
CANCER RESEARCH (2008)
The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway
Chiara Laezza et al.
ENDOCRINE-RELATED CANCER (2008)
Endocannabinoids in endocrine and related tumours
Maurizio Bifulco et al.
ENDOCRINE-RELATED CANCER (2008)
Expression and function of fatty acid amide hydrolase in prostate cancer
Michael P. Endsley et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression and Secretion of N-acylethanolamine-hydrolysing Acid Amidase in Human Prostate Cancer Cells
Jun Wang et al.
JOURNAL OF BIOCHEMISTRY (2008)
A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain
Iryna A. Khasabova et al.
JOURNAL OF NEUROSCIENCE (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells
M. M. Caffarel et al.
ONCOGENE (2008)
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain
Andreas Hald et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Δ9-tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling
Shuso Takeda et al.
TOXICOLOGY (2008)
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
Mellar P. Davis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
M. D. Jhaveri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol as a novel inhibitor of ld-1 gene expression in aggressive breast cancer cells
Sean D. McAllister et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism
Michael P. Endsley et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cannabinoids and gliomas
Guillermo Velasco et al.
MOLECULAR NEUROBIOLOGY (2007)
Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
Andrew G. Glass et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia
Darryl T. Hamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest
Sami Sarfaraz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
Daniela Sarnataro et al.
MOLECULAR PHARMACOLOGY (2006)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Maria M. Caffarel et al.
CANCER RESEARCH (2006)
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi et al.
EXPERIMENTAL CELL RESEARCH (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells
D Sarnataro et al.
FEBS LETTERS (2005)
Cannabinoids and cancer
NM Kogan
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells
K Nithipatikom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
Cannabinoid receptor as a novel target for the treatment of prostate cancer
S Sarfaraz et al.
CANCER RESEARCH (2005)
Marijuana extracts possess the effects like the endocrine disrupting chemicals
K Watanabe et al.
TOXICOLOGY (2005)
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells:: synthesis of new transporter inhibitors as tools for this study
L Ruiz-Llorente et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
2-arachidonoylglycerol: A novel inhibitor of androgen-independent prostate cancer cell invasion
K Nithipatikom et al.
CANCER RESEARCH (2004)
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways
VA Movsesyan et al.
CELL DEATH AND DIFFERENTIATION (2004)
Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells
MG Sánchez et al.
FEBS LETTERS (2003)
Activation of phosphoinositide 3-kinase/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells.: Involvement in Raf-1 stimulation and NGF induction
MG Sánchez et al.
CELLULAR SIGNALLING (2003)
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines:: Implication of epidermal growth factor receptor down-regulation and ceramide production
M Mimeault et al.
PROSTATE (2003)
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems
L De Petrocellis et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
V Di Marzo et al.
BIOCHEMICAL JOURNAL (2001)
Δ9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells -: Involvement of CB1 cannabinoid receptor and Raf-1
L Velasco et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Anandamide induces apoptosis in human cells via vanilloid receptors -: Evidence for a protective role of cannabinoid receptors
M Maccarrone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Suppression of nerve growth factor trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
D Melck et al.
ENDOCRINOLOGY (2000)
Share Paper
